Val/Leu247 and Trp/Ser316 polymorphisms in β2 glycoprotein I and their association with thrombosis in unselected Chilean patients

Clinical Rheumatology

Volumn 26, Issue 3, 2007, Pages 302-307

  Palomo, Iván ^a   Pereira, Jaime ^b   Alarcon M Marcelo ^a   Vásquez, Marcela ^a   Pinochet, Carmen ^c   Poblete, Fernando ^a   Mendez, Evelyn ^a   Sandoval, Jeannette ^a   Vidal, Rolando ^a   Pierangeli, Silvia ^d  

^a UNIVERSIDAD DE TALCA   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSIDAD SAN SEBASTIÁN   (Chile)

^d MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Anti 2GPI antibody; Antiphospholipid antibody; ApolipoproteinH; Arterial thrombosis; Polymorphism; Venous thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; LEUCINE; PHOSPHOLIPID ANTIBODY; SERINE; TRYPTOPHAN; VALINE;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; CHILE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THROMBOEMBOLISM; VEIN THROMBOSIS; BLOOD; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY THROMBOSIS; ETHNOLOGY; GENETICS; IMMUNOLOGY; MIDDLE AGED; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOPHILIA;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; BETA 2-GLYCOPROTEIN I; CEREBROVASCULAR ACCIDENT; CHILE; CORONARY THROMBOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 33947656457     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0289-z     Document Type: Article

References (37)

1. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA (1990) Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: Beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 87(11):4120-4124
2. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJ, Barbui T, Zwaal RF, Bevers EM (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335(8705):1544-1547
3. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T (1990) Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336(8708):177-178
4. Bevers EM, Galli M (1990) Beta 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet 336(8720):952-953
5. Oosting JD, Derksen RH, Entjes HT, Bouma BN, de Groot PG (1992) Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein I. Thromb Haemost 67(5):499-502
6. Palomo I, Pereira J (1997) Anticuerpos antifosfolípidos y su principal blanco, la beta 2-glicoproteína I. Revista Chilena de Tecnología Médica 17:790-796
7. Kamboh MI, Wagenknecht DR, McIntyre JA (1995) Heterogeneity of the apolipoprotein H*3 allele and its role in affecting the binding of apolipoprotein H (beta 2-glycoprotein I) to anionic phospholipids. Hum Genet 95(4):385-388
8. Mehdi H, Aston CE, Sanghera DK, Hamman RF, Kamboh MI (1999) Genetic variation in the apolipoprotein H (beta2-glycoprotein I) gene affects plasma apolipoprotein H concentrations. Hum Genet 105(1-2):63-71
9. Gushiken FC, Arnett FC, Ahn C, Thiagarajan P (1999) Polymorphism of beta2-glycoprotein I at codons 306 and 316 in patients with systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 42(6):1189-1193
10. Palomo I, Pereira J, Alarcón M, Vásquez M (2000) Anticuerpos asociados a trombosis. Rev Chil Cancerol y Hematol 10:69-78
11. Schousboe I (1985) beta 2-Glycoprotein I: A plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 66(5):1086-1091
12. Okkels H, Rasmussen TE, Sanghera DK, Kamboh MI, Kristensen T (1999) Structure of the human beta2-glycoprotein I (apolipoprotein H) gene. Eur J Biochem 259(1-2):435-440
13. Steinkasserer A, Cockburn DJ, Black DM, Boyd Y, Solomon E, Sim RB (1992) Assignment of apolipoprotein H (APOH: Beta-2-glycoprotein I) to human chromosome 17q23-qter; determination of the major expression site. Cytogenet Cell Genet 60(1):31-33
14. Bendixen E, Halkier T, Magnusson S, Sottrup-Jensen L, Kristensen T (1992) Complete primary structure of bovine beta 2-glycoprotein I: localization of the disulfide bridges. Biochemistry 31(14):3611-3617
15. Kato H, Enjyoji K (1991) Amino acid sequence and location of the disulfide bonds in bovine beta 2 glycoprotein I: The presence of five Sushi domains. Biochemistry 30(50):11687-11694
16. Hirose N, Williams R, Alberts AR, Furie RA, Chartash EK, Jain RI, Sison C, Lahita RG, Merrill JT, Cucurull E, Gharavi AE, Sammaritano LR, Salmon JE, Hashimoto S, Sawada T, Chu CC, Gregersen PK, Chiorazzi N (1999) A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndrome. Arthritis Rheum 42(8):1655-1661
17. Richter A, Cleve H (1988) Genetic variations of human serum beta 2-glycoprotein I demonstrated by isoelectric focusing. Electrophoresis 9(7):317-322
18. Sanghera DK, Kristensen T, Hamman RF, Kamboh MI (1997) Molecular basis of the apolipoprotein H (beta 2-glycoprotein I) protein polymorphism. Hum Genet 100(1):57-62
19. Steinkasserer A, Weiss EH, Schwaeble W, Linke RP (1990) Heterogeneity of human serum amyloid A protein. Five different variants from one individual demonstrated by cDNA sequence analysis. Biochem J 268(1):187-193
20. Steinkasserer A, Dorner C, Wurzner R, Sim RB (1993) Human beta 2-glycoprotein I: Molecular analysis of DNA and amino acid polymorphism. Hum Genet 91(4):401-402
21. Sheng Y, Sali A, Herzog H, Lahnstein J, Krilis SA (1996) Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J Immunol 157(8):3744-3751
22. Camilleri R, Mackie I, Humphries S, Machin S, Cohen H (2003) Lack of association of beta2-glycoprotein I polymorphism Val247Leu and Trp316Ser with antiphospholipid antibodies in patients with thrombosis and pregnancy complications. Br J Haematol 120(6):1066-1072
23. Horbach DA, van Oort E, Tempelman MJ, Derksen RH, de Groot PG (1998) The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma-consequences for the development of anti-beta2-glycoprotein I antibodies. Thromb Haemost 80(5):791-797
24. Yasuda S, Atsumi T, Matsuura E, Kaihara K, Yamamoto D, Ichikawa K, Koike T (2005) Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: Increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant. Arthritis Rheum 52(1):212-218
25. Atsumi T, Tsutsumi A, Amengual O, Khamashta MA, Hughes GR, Miyoshi Y, Ichikawa K, Koike T (1999) Correlation between b2-glycoprotein I valine/ leucine247 polymorphism and anti-b2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome. Rheumatology (Oxford) 38:721-723
26. Prieto G, Cabral A, Zapata-Zuñiga M, Simon A, Villa A, Alarcon-Segovia D, Cabiedes J (2003) Valine/valine genotype at position 247 of the beta2-glycoprotein I gene in Mexican patients with primary antiphospholipid syndrome: Association with anti-beta2-glycoprotein I antibodies. Arthritis Rheum 48(2):471-474
27. Lahiri D, Nurmberger J (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19(19):5444
28. Palomo I, Pereira J, Alarcon M, Vasquez M, Pinochet C, Velez MT, Sandoval J, Icaza G, Pierangeli S (2004) Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis. Clin Rheumatol 23(2):129-133
29. Matsuura E, Igarashi Y, Yasuda T, Triplett D, Koike T (1994) Anticardiolipin antibodies recognize b2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179(2):457-462
30. Polz E, Wurm H, Kostner GM (1980) Investigations on beta 2-glycoprotein-I in the rat: Isolation from serum and demonstration in lipoprotein density fractions. Int J Biochem 11(3-4):265-270
31. Palomo I, Alarcon M, Sepulveda C, Pereira J, Espinola R, Pierangeli S (2003) Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients. J Clin Lab Anal 17(6):209-215
32. Palomo I, Pereira J, Alarcon M, Larrain AM, Pinochet C, Vasquez M, Velez MT, Leon M, Espinola R, Pierangeli S (2002) Antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus. J Lab Clin Med 140(5):336-341
33. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN (1985) Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): Standardization and quantitation of results. Clin Exp Immunol 62(3):738-745
34. Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colomb MG (1995) Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 74(4):1120-1125
35. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 42(7):1309-1311
36. Sanghera D, Wagenknecht D, McIntyre J, Kamboh MI (1997) Identification of structural mutations in the fifth domain of apolipoprotein H (b2-glycoprotein I) which affect phospholipid binding. Hum Mol Genet 6:311-316
37. Kamboh MI, Manzi S, Mehdi H, Fitzgerald S, Sanghera DK, Kuller L, Atson C (1999) Genetics variation in apolipopreotein H (beta2-glycoprotein I) affects the occurrence of antiphospholipid antibodies and apolipoprotein H concentrationists in systemic lupus eruthematosus. Lupus 8(9):742-750